↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

39 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Abatacept   Abatacept   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 2   Acz885   -   -   -   -   5件:
46,
84,
106,
107,
108 
 3   Acz885 drug substance   -   -   -   -   2件:
46,
107 
 4   Anakinra   Anakinra   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   15件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
84,
86,
106,
107,
299 
 5   Anakinra / kineret   Anakinra   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   1件:
107 
 6   Baricitinib   Baricitinib   D10308   2件: JAK1, JAK2   3件: Chemokine signaling pathway, JAK-STAT signaling pathway, Osteoclast differentiation   8件:
41,
46,
49,
50,
93,
107,
265,
325 
 7   Canakinumab   Canakinumab   D09315   1件: IL1B   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NOD-like receptor signaling pathway   9件:
46,
56,
84,
106,
107,
108,
113,
266,
269 
 8   Emapalumab   Emapalumab   D11120   -   -   1件:
107 
 9   Fully human anti-interferon gamma monoclonal antibody   -   -   -   -   1件:
107 
 10   Heparin   Heparin   D07510   1件: SERPINC1   1件: Complement and coagulation cascades   11件:
60,
70,
79,
84,
107,
224,
226,
280,
299,
316,
317 
 11   Il-6 receptor inhibitor, recombinant humanized monoclonal antibody   -   -   -   -   2件:
46,
107 
 12   Ilaris   Canakinumab   D09315   1件: IL1B   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NOD-like receptor signaling pathway   6件:
56,
84,
106,
107,
108,
266 
 13   In double-blind phase: treatment with tofacitinib   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   1件:
107 
 14   In open-label phase: treatment with tofacitinib   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   1件:
107 
 15   Itf2357   -   -   -   -   3件:
96,
107,
113 
 16   Kineret*sc 7sir 100mg 0,67ml   Anakinra   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   2件:
46,
107 
 17   Kineret® or anakinra   Anakinra   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   1件:
107 
 18   Mra (tocilizumab)   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   2件:
46,
107 
 19   Mra(tocilizumab)   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   2件:
46,
107 
 20   Ni-0501   -   -   -   -   1件:
107 
 21   Nsaids   -   -   -   -   4件:
46,
70,
107,
271 
 22   Null   -   -   -   -   17件:
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 23   Pneumo23   -   -   -   -   1件:
107 
 24   Recombinant antihumanized anti-human monoclonal antibody directed against the il-6r   -   -   -   -   1件:
107 
 25   Recombinant human monoclonal antibody to human il-1beta of the igg1/k class   -   -   -   -   3件:
106,
107,
108 
 26   Regn88   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   2件:
46,
107 
 27   Ril-1ra   -   -   -   -   1件:
107 
 28   Rilonacept   Rilonacept   D06635   2件: IL1A, IL1B   4件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Toll-like receptor signaling pathway   4件:
51,
106,
107,
266 
 29   Rilonacept (il-1 trap)   Rilonacept   D06635   2件: IL1A, IL1B   4件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Toll-like receptor signaling pathway   1件:
107 
 30   Ro 487-7533/f10-04   -   -   -   -   4件:
41,
46,
51,
107 
 31   Ro4877533 (tcz)   -   -   -   -   2件:
46,
107 
 32   Roactemra   -   -   -   -   5件:
41,
46,
51,
86,
107 
 33   Sar153191   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   4件:
41,
46,
107,
271 
 34   Sar153191 (regn88)   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   2件:
46,
107 
 35   Sarilumab   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   4件:
41,
46,
84,
107 
 36   Sarilumab sar153191 (regn88)   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   2件:
46,
107 
 37   Tocilizumab   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331 
 38   Tocilizumab sc   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   3件:
41,
46,
107 
 39   Tofacitinib   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   9件:
46,
49,
50,
51,
84,
96,
97,
107,
271 

先頭へ